Aspen Neuroscience

San Diego, CA · Founded 2018 · Privately Held (backing)

Developer of autologous cell therapies and personalized medicines designed for a broad spectrum of diseases, starting with Parkinson's disease. Aspen Neuroscience is based in San Diego, CA and was founded in 2018. Its last reported valuation was $346 million in Sep 2025. It has raised $379 million.

Last reported valuation
$346.0M
Oct 2026
Priced at
—
Total raised
$379.3M
Last round
—

Who backs Aspen Neuroscience?

26 investors
InvestorType
GaingelsVenture capital
GVVenture capital
Alexandria Venture InvestmentsOther
OrbiMedGrowth equity
Mirae Asset CapitalVenture capital
EDBIVenture capital
ARCH Venture PartnersVenture capital
S32Venture capital
Cormorant Asset ManagementVenture capital
Frazier Healthcare PartnersVenture capital
+ 16 more investors · a free account shows the complete list
The directory is free. Investor activity — the working column — is Pro.Unlock prospecting columns

Membership and data by Private Market View

Aspen Neuroscience investors

26 investors are on record for Aspen Neuroscience, including Gaingels, GV, Alexandria Venture Investments and OrbiMed. By type, the record holds 13 venture capital firms and 1 hedge fund.

Free account
More of Aspen Neuroscience with a free account
  • ·The complete investor list: 26 names
  • ·Watch Aspen Neuroscience: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

For fundraisers
Work this list, don’t just read it

These 26 firms already write checks for companies like Aspen Neuroscience. Build the wider list: every firm that has backed a company like this one, ranked by how often and how recently.

Find investors like these →

Membership and data by Private Market View